At its typical dose, semaglutide has a half-life of 7 days and is administered once weekly for 45 weeks to achieve steady state, or consistent levels in the body
However, experts have expressed concern over the safety of compounded GLP-1 medications due to their lack of oversight and regulation
Semaglutide and tirzepatide are the two most talked-about prescription weight loss injections available today
Conversely, if you are on multiple medications, changes in absorption could theoretically impact your risk of hypoglycemia (low blood sugar)
Post-medication weight trends A study tracked participants after they stopped semaglutide (Wegovy) and showed: Average weight loss after 68 weeks on medication: 17.3% Average weight after 52 weeks post-medication: 5.6% below baseline Weight regained: 11.6% (67% of lost weight) This research demonstrates that without addressing underlying habits, significant weight regain is common after stopping medication
The kit was easy to use and I have already ordered my second month The process was easy and the product was received quickly and as promised